Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Genet Mol Res ; 14(3): 8100-16, 2015 Jul 17.
Artigo em Inglês | MEDLINE | ID: mdl-26214493

RESUMO

Xylan is a heteropolysaccharide and its complete hydrolysis involves a complex set of xylanolytic enzymes. Fungal xylanases have been widely used in the holocellulose industry to obtain by-products or for its elimination. The aim of this study was to select and identify filamentous fungi from different ecosystems that produce extracellular xylanases showing biotechnological potential. One hundred three fungal isolates were obtained from orchard, horticultural, and forest ecosystems. The ability of fungi to degrade xylan was measured by quantifying their xylanolytic indices after growth on solid culture media and their extracellular xylanolytic and cellulolytic activities after submerged fermentation. All fungal isolates grew on solid medium supplemented with xylan as the sole carbon source, but only 44% of isolates showed xylanolytic indices greater than 1.0. In submerged fermentation, 39% of the fungi tested showed no cellulolytic activity. Filamentous fungi were chosen from correspondence analysis and were identified by molecular tools using internal transcribed spacers. One of the 9 isolates selected belonged to the Phoma genus and the remaining were from the Fusarium genus. Fusarium solani (isolate 59) showed the highest xylanolytic index (0.964 ± 0.042), rapid growth on solid medium (1.233 ± 0.050 cm/day), significant xylanolytic activity (3.823 ± 0.210 U/mg), and a total deficiency of cellulolytic activity compared to other fungal isolates. In the zymogram, a clear zone was observed, indicating that F. solani possesses at least 1 xylanase. Fusarium solani was selected for its ability to produce extracellular xylanases with biotechnological potential.


Assuntos
Endo-1,4-beta-Xilanases/metabolismo , Proteínas Fúngicas/metabolismo , Fungos/enzimologia , Fungos/isolamento & purificação , Xilanos/metabolismo , Celulose/metabolismo , Eletroforese em Gel de Poliacrilamida , Reação em Cadeia da Polimerase
2.
Gene ; 533(2): 508-14, 2014 Jan 10.
Artigo em Inglês | MEDLINE | ID: mdl-24080485

RESUMO

Metals are a threat to human health by increasing disease risk. Experimental data have linked altered miRNA expression with exposure to some metals. MiRNAs comprise a large family of non-coding single-stranded molecules that primarily function to negatively regulate gene expression post-transcriptionally. Although several human populations are exposed to low concentrations of As, Cd and Pb as a mixture, most toxicology research focuses on the individual effects that these metals exert. Thus, this study aims to evaluate global miRNA and mRNA expression changes induced by a metal mixture containing NaAsO2, CdCl2, Pb(C2H3O2)2·3H2O and to predict possible metal-associated disease development under these conditions. Our results show that this metal mixture results in a miRNA expression profile that may be responsible for the mRNA expression changes observed under experimental conditions in which coding proteins are involved in cellular processes, including cell death, growth and proliferation related to the metal-associated inflammatory response and cancer.


Assuntos
Expressão Gênica/efeitos dos fármacos , Metais/toxicidade , MicroRNAs/genética , RNA Mensageiro/genética , Animais , Arsenitos/toxicidade , Células 3T3 BALB , Cloreto de Cádmio/toxicidade , Transformação Celular Neoplásica/efeitos dos fármacos , Transformação Celular Neoplásica/genética , Perfilação da Expressão Gênica , Saúde , Camundongos , Análise em Microsséries , Compostos Organometálicos/toxicidade , Transdução de Sinais/efeitos dos fármacos , Transdução de Sinais/genética , Compostos de Sódio/toxicidade , Testes de Toxicidade
3.
Genet Mol Res ; 11(3): 2665-73, 2012 Aug 16.
Artigo em Inglês | MEDLINE | ID: mdl-22869080

RESUMO

We looked for bacterial strains with antifungal activity in the sorghum rhizosphere. A prescreening procedure to search for hemolytic activity among the isolated strains allowed us to detect good fungitoxic activity in a bacterial isolate that we named UM96. This bacterial isolate showed strong growth inhibition in bioassays against the pathogens Diaporthe phaseolorum, Colletotrichum acutatum, Rhizoctonia solani, and Fusarium oxysporum. The supernatant of isolate UM96 also showed strong hemolytic activity, which was not observed in the protease-treated supernatant. However, the supernatant that was treated with protease had similar antagonistic effects to those exhibited by the supernatant that was not treated with this enzyme. These results suggest that a bacteriocin-like compound is responsible for the hemolytic activity; whereas, as far as antifungal effect is concerned, an antibiotic of nonribosomal origin, such as a lipopeptide, might be acting. Further molecular characterization by partial 16S rDNA sequencing placed isolate UM96 in a cluster with Bacillus amyloliquefaciens; however, the highest identity match found in databases of Bacillus species was 91% identity. This suggests that Bacillus sp UM96 might be a novel species.


Assuntos
Antifúngicos/farmacologia , Bacillus/genética , Bacillus/isolamento & purificação , Fungos/efeitos dos fármacos , Rizosfera , Sorghum/microbiologia , Sequência de Bases , DNA Ribossômico/genética , Fungos/crescimento & desenvolvimento , Genes Bacterianos/genética , Hemólise/efeitos dos fármacos , Testes de Sensibilidade Microbiana , Dados de Sequência Molecular
4.
Antonie Van Leeuwenhoek ; 68(3): 203-8, 1995 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-8572677

RESUMO

Bacillus strain QC1-2, isolated from a chromium-polluted zone, was selected by its high ability to both tolerate and reduce hexavalent chromium [Cr(VI)] to less-toxic trivalent chromium [Cr(III)]. Cell suspensions of strain QC1-2 rapidly reduced Cr(VI), in both aerobic and anaerobic conditions, to Cr(III) which remained in the supernatant. Cr(VI) reduction was dependent on the addition of glucose but sulfate, an inhibitor of chromate transport, had no effect. Studies with permeabilized cells and cell extracts showed that the Cr(VI) reductase of strain QC1-2 is a soluble NADH-dependent enzyme.


Assuntos
Bacillus/metabolismo , Proteínas de Bactérias/metabolismo , Cromatos/metabolismo , Oxirredutases/metabolismo , Aerobiose , Anaerobiose , Bacillus/efeitos dos fármacos , Bacillus subtilis/efeitos dos fármacos , Bacillus subtilis/metabolismo , Permeabilidade da Membrana Celular , Cromatos/farmacologia , Resistência Microbiana a Medicamentos , Glucose/metabolismo , Oxirredução , Pseudomonas aeruginosa/efeitos dos fármacos , Pseudomonas aeruginosa/metabolismo , Sulfatos/farmacologia
5.
Arch Microbiol ; 151(1): 10-4, 1989.
Artigo em Inglês | MEDLINE | ID: mdl-2916900

RESUMO

Diamino butanone (DAB), a competitive inhibitor of ornithine decarboxylase (ODC) a key enzyme in polyamine biosynthesis, inhibited the yeast to hyphae transition in Mucor rouxii, induced by transfer from anaerobiosis to aerobiosis, but not the opposite phenomenon. Addition of DAB to anaerobic yeast cells brought about a decrease in ODC and polyamine levels. In these conditions, the aerobic shift produced only a weak increase in ODC activity and no change in polyamine levels. DAB also blocked phorogenesis in M. rouxii and in Phycomyces blakesleeanus. At the effective concentrations DAB did not affect cell growth of either fungus. It is suggested that low, constant levels of ODC and polyamines are necessary for cell growth, and that high transient levels are required during the differentiative steps. DAB, at the concentrations used, affects this last process, but does not interfere with the maintenance level of polyamines.


Assuntos
Mucorales/efeitos dos fármacos , Putrescina/análogos & derivados , Diferenciação Celular/efeitos dos fármacos , Mucor/efeitos dos fármacos , Mucor/crescimento & desenvolvimento , Mucor/metabolismo , Mucorales/crescimento & desenvolvimento , Mucorales/metabolismo , Inibidores da Ornitina Descarboxilase , Phycomyces/efeitos dos fármacos , Phycomyces/crescimento & desenvolvimento , Phycomyces/metabolismo , Poliaminas/biossíntese , Putrescina/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...